Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin carboxyl-terminal esterase L1 pseudogene (ENSG00000254411; LOC100128210) is a non-functional genomic locus related to the UCHL1 gene, which encodes a deubiquitinating enzyme involved in proteostasis and is expressed in neurons. Pseudogenes such as ENSG00000254411 do not encode functional proteins, are not involved in canonical biological processes, and are not recognized therapeutic targets. All known functional, disease-related, or therapeutic roles in the literature pertain to the protein-coding UCHL1 gene, not to this pseudogene. Identification of ENSG00000254411 as a target for pharmacological intervention is incorrect; for therapeutic, mechanistic, or biomarker context, the corresponding protein-coding gene (UCHL1) should be referenced instead[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin carboxyl-terminal esterase L1 pseudogene.